Market Research Logo

Vietnam Pharmaceuticals and Healthcare Report Q2 2016

Vietnam Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Vietnam's disease profile will be increasingly attractive for prescription drugmakers as chronicconditions become more prevalent. To adequately meet this large unmet medical need, pharmaceuticalfirms will have to adapt their product portfolios to account for the low purchasing power of the populace.Equally critical will be the need to coordinate with local healthcare institutions to improve Vietnam'sdiagnosis rates, which remain impeded by its underdeveloped medical system.Headline Expenditure Projections

Pharmaceuticals: VND92.471trn (USD4.22bn) in 2015 to VND105.482trn (USD4.61bn) in 2016;+14.1% in local currency terms and +9.2% in US dollar terms. Forecast largely unchanged from lastquarter.

Healthcare: VND260.29trn (USD11.9bn) in 2015 to VND286.45bn (USD12.5bn) in 2016; +10.1% inlocal currency terms and +5.4% in US dollar terms. Forecast largely unchanged from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Vietnam 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
OTC Medicine Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2014-2020)
Pharmaceuticals & Healthcare Risk/Reward Index
Asia Pacific Risk/Reward Index
Vietnam Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Vietnam 2010-2015)
Table: Healthcare Personnel (Vietnam 2010-2015)
Table: Healthcare Activity (Vietnam 2010-2015)
Research & Development
Clinical Trials
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries
Company Profile
DHG Pharmaceutical
GlaxoSmithKline
Sanofi
Traphaco Pharmaceutical
Vietnam Pharmaceutical Corporation (Vinapharm)
Demographic Forecast
Table: Population Headline Indicators (Vietnam 1990-2025)
Table: Key Population Ratios (Vietnam 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Vietnam 1990-2025)
Table: Population By Age Group (Vietnam 1990-2025)
Table: Population By Age Group % (Vietnam 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report